Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares

Ann Rheum Dis. 2021 Dec;80(12):e200. doi: 10.1136/annrheumdis-2019-216639. Epub 2019 Dec 2.

Authors

Arnaud M Didierlaurent¹, Christophe Desssart², Anthony L Cunningham³

Affiliations

¹ GSK, Wavre, Belgium arnaud.x.didierlaurent@gsk.com.
² GSK, Wavre, Belgium.
³ Centre for Virus Research, The Westmead Institute for Medical Research, University of Sydney, Australia, Westmead, New South Wales, Australia.

PMID: 31791949
DOI: 10.1136/annrheumdis-2019-216639

No abstract available

Keywords: gout; infections; vaccination.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Gout*
Herpes Zoster Vaccine*
Herpes Zoster* / prevention & control
Humans
Symptom Flare Up
Vaccines, Synthetic

Substances

Herpes Zoster Vaccine
Vaccines, Synthetic